Marek Health Prescription Process: How the Intake, Labs, and Prescribing Actually Work

What Is Marek Health and Is It a Legitimate Clinic?

Marek Health is a telemedicine-forward clinic that focuses on hormone optimization, TRT, and peptide prescribing. It was co-founded by Derek, known publicly through his More Plates More Dates content platform, alongside board-certified physicians. The clinic operates as a cash-pay practice, meaning it does not bill insurance carriers directly.

Legitimacy in telehealth hormone clinics depends on verifiable criteria: active state medical licenses for prescribers, DEA registrations for controlled substances, adherence to prescribing guidelines, and use of accredited pharmacies. The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism requires a confirmed diagnosis based on both symptoms and at least two morning serum testosterone measurements below 300 ng/dL before initiating TRT [1]. Any clinic prescribing testosterone without verifying these diagnostic thresholds is operating outside accepted medical standards.

Marek Health states that it requires bloodwork before prescribing. This is a baseline expectation. The American Urological Association (AUA) similarly recommends against empiric testosterone prescribing without biochemical confirmation [2]. Whether a specific clinic consistently enforces these standards is difficult to verify externally, but the stated protocol aligns with guideline recommendations. Patients should confirm their provider reviews labs before writing prescriptions and does not rely solely on symptom questionnaires.

Step-by-Step Intake Process

The intake funnel at Marek Health follows a pattern common to concierge telehealth hormone clinics, though with a heavier emphasis on comprehensive lab panels than many competitors offer.

Step 1: Online application. Prospective patients complete a health history questionnaire covering symptoms, prior diagnoses, current medications, and treatment goals. This typically takes 15 to 30 minutes.

Step 2: Lab order. After application review, the clinic issues a lab requisition. Marek Health generally orders broad panels (40+ markers) rather than the minimal testosterone-only checks some clinics use. A standard panel includes total testosterone, free testosterone (by equilibrium dialysis or LC-MS/MS), SHBG, estradiol (sensitive assay), LH, FSH, prolactin, CBC, CMP, lipid panel, hemoglobin A1c, thyroid panel, PSA (for men over 40), and IGF-1. The Endocrine Society recommends measuring testosterone using a reliable assay such as LC-MS/MS rather than direct immunoassay, which can be inaccurate at low concentrations [1].

Step 3: Provider consultation. A licensed clinician reviews the labs and conducts a telemedicine visit (or in-person where available). This visit typically runs 30 to 60 minutes for new patients. The provider discusses findings, explains treatment options, and establishes a plan if clinically indicated.

Step 4: Prescribing and pharmacy fulfillment. If treatment is warranted, prescriptions route to a compounding pharmacy. Medications ship directly to the patient. Common prescriptions include testosterone cypionate (100 to 200 mg per week is the typical TRT dose range), anastrozole if estradiol management is needed, and gonadorelin or enclomiphene for fertility preservation during TRT [3].

Step 5: Follow-up labs and monitoring. The clinic schedules repeat bloodwork at 6 to 12 week intervals initially, then every 3 to 6 months once stable. The Endocrine Society recommends checking hematocrit at baseline, 3 to 6 months, then annually, given that testosterone therapy increases erythropoiesis and can raise hematocrit above 54%, at which point dose reduction or therapeutic phlebotomy is indicated [1].

What Does Marek Health Prescribe?

The clinic's prescribing scope covers several categories: testosterone replacement, peptide therapy, thyroid optimization, and metabolic support compounds. Each comes with different levels of clinical evidence.

Testosterone replacement is the best-supported offering. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, demonstrated that testosterone replacement in men aged 45 to 80 with hypogonadism and cardiovascular risk did not increase the incidence of major adverse cardiac events compared to placebo [4]. This was a significant finding because cardiovascular safety had been a longstanding concern. The trial confirmed that TRT is reasonably safe from a cardiac standpoint in appropriately selected patients over a mean follow-up of 33 months.

Peptide therapy is more complex from an evidence standpoint. Marek Health has offered peptides such as BPC-157, CJC-1295/Ipamorelin combinations, and others. The FDA issued warning letters in 2023 to multiple compounding pharmacies regarding certain peptides, and BPC-157 was placed on the FDA's "difficult to compound" list in late 2024, effectively restricting its availability through 503A pharmacies [5]. Patients considering peptide therapy should verify that any prescribed compound is legally available and that the pharmacy holds appropriate licensure.

Thyroid and metabolic prescribing may include low-dose thyroid hormone, metformin (off-label for longevity or prediabetes management), and DHEA. Metformin's potential longevity benefits are being formally tested in the TAME trial (Targeting Aging with Metformin), though results are not yet published [6]. Prescribing metformin off-label for "optimization" in metabolically healthy individuals remains controversial, and the American Diabetes Association recommends metformin specifically for patients with prediabetes who are under 60, have a BMI of 35 or higher, or have a history of gestational diabetes [7].

Cost Breakdown: What Patients Actually Pay

Marek Health operates entirely outside insurance networks. Every cost is out-of-pocket.

The initial consultation runs approximately $250. Follow-up visits range from $100 to $200 depending on complexity. Lab panels through their partnered draw networks typically cost $300 to $500 for comprehensive panels, though prices vary by location and panel scope. Testosterone cypionate from compounding pharmacies generally costs $50 to $150 per month depending on dose and pharmacy. Peptide costs, when available, have historically ranged from $150 to $400 per month per compound.

Annual all-in spending for a TRT patient at Marek Health typically falls between $2,400 and $5,000, including labs, consultations, and medications. By comparison, a patient using insurance-covered testosterone cypionate (generic, commercially manufactured) through a primary care physician or endocrinologist might pay $30 to $75 per month for medication with standard copays, plus standard office visit costs. The GoodRx cash price for a 10 mL vial of testosterone cypionate 200 mg/mL (a roughly 10-week supply at 200 mg/week) is approximately $40 to $90 at retail pharmacies [8].

The cost premium at concierge clinics like Marek Health buys more comprehensive lab monitoring, longer consultation times, and access to compounds not available at retail pharmacies. Whether that premium is worthwhile depends on whether a patient's needs exceed what a standard endocrinology or urology practice provides.

Marek Health vs. Alternatives: How It Compares

The telehealth TRT and hormone optimization market has grown rapidly. Competitors include clinics like Defy Medical, Peter Uncaged MD, TRT Nation, and direct-to-consumer platforms such as Hone Health and Ro.

Lab comprehensiveness is where Marek Health distinguishes itself. Many DTC platforms order only total testosterone and a basic metabolic panel before prescribing. The Endocrine Society explicitly recommends measuring LH and FSH to differentiate primary from secondary hypogonadism, and checking prolactin to rule out pituitary pathology when testosterone is below 150 ng/dL [1]. A clinic ordering 40+ markers at baseline exceeds the minimum diagnostic standard. This matters clinically because secondary hypogonadism caused by a prolactinoma, for example, requires a completely different treatment approach than primary testicular failure.

Provider time is another differentiator. Standard telemedicine TRT mills may limit consultations to 10 to 15 minutes. Marek Health advertises longer initial visits. Whether longer consultations translate to better outcomes has not been studied in the TRT context specifically, but a 2019 systematic review in BMJ Open found that longer primary care consultations were associated with improved patient outcomes across multiple metrics [9].

Prescribing philosophy varies significantly across clinics. Some clinics prescribe testosterone to any man reporting fatigue or low libido, regardless of lab values. This practice contradicts the AUA guideline, which defines testosterone deficiency as a total testosterone below 300 ng/dL on two separate morning samples [2]. Marek Health's stated requirement for bloodwork before prescribing aligns with guidelines, though prospective patients should verify this in practice during their own intake process.

Cost comparison favors insurance-based care for straightforward TRT. A man with confirmed hypogonadism whose endocrinologist prescribes generic testosterone cypionate and monitors labs through standard insurance-covered blood draws will spend a fraction of what concierge care costs. The concierge model makes more sense for patients seeking compounds not covered by insurance, wanting more extensive lab panels, or preferring a provider with specific expertise in optimization-focused protocols.

Monitoring and Safety: What Guidelines Require

Ongoing monitoring during TRT is not optional. The Endocrine Society guideline specifies the following surveillance schedule: measure testosterone and hematocrit at 3 to 6 months after starting therapy, then annually; check bone mineral density by DXA after 1 to 2 years in men with osteoporosis at baseline; and perform digital rectal exam and PSA at 3 to 6 months, then per standard screening guidelines [1].

Polycythemia (hematocrit above 54%) is the most common laboratory adverse effect of TRT. A retrospective cohort study of 3,422 men on TRT published in the Journal of Clinical Endocrinology and Metabolism found that 11.2% developed polycythemia during follow-up [10]. This risk increases with higher doses and with injectable formulations compared to transdermal testosterone. Any clinic that does not check hematocrit regularly is failing a basic safety obligation.

Cardiovascular monitoring matters too. While the TRAVERSE trial was reassuring regarding major adverse cardiac events [4], the same trial found a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. These findings reinforce the need for regular follow-up rather than "set and forget" prescribing.

For men concerned about fertility, exogenous testosterone suppresses spermatogenesis by reducing intratesticular testosterone concentrations. Recovery after discontinuation is variable. A 2019 analysis of 11 studies found that 67% of men recovered to baseline sperm concentrations within 6 months of stopping testosterone, but some required 12 months or longer [11]. Clinics offering concurrent hCG or enclomiphene aim to mitigate this suppression, though the evidence base for co-administration protocols during TRT is limited primarily to small observational studies.

Red Flags to Watch for at Any Hormone Clinic

Not every telehealth hormone clinic operates responsibly. These are evidence-based warning signs, applicable to Marek Health or any competitor.

Prescribing without labs is the most significant red flag. The AUA and Endocrine Society both require biochemical confirmation of hypogonadism [1][2]. A clinic that prescribes testosterone based solely on a symptom questionnaire is practicing below the standard of care.

No follow-up lab schedule is equally concerning. One-time prescribing without ongoing hematocrit, PSA, and testosterone level monitoring creates preventable risk.

Supraphysiologic dosing without justification should raise concern. TRT aims for mid-normal testosterone levels (450 to 700 ng/dL in most guidelines). Prescribing doses that produce levels above 1,000 ng/dL is not TRT. It is androgen enhancement, which carries a different risk profile including greater polycythemia risk, lipid derangement, and left ventricular hypertrophy as observed in studies of anabolic steroid users [12].

Pushing unnecessary add-ons is a financial red flag. Not every TRT patient needs an aromatase inhibitor, a growth hormone secretagogue, or a peptide stack. The Endocrine Society recommends against routine anastrozole co-prescribing with TRT unless estradiol-related side effects are documented [1]. A clinic that bundles expensive add-ons into every protocol may be optimizing revenue rather than patient outcomes.

What the Intake Timeline Looks Like in Practice

From application to first injection, most patients report a 1 to 3 week timeline at Marek Health. The primary bottleneck is lab scheduling and result turnaround. Quest Diagnostics and Labcorp, the two largest commercial lab networks in the United States, typically return results in 3 to 5 business days for standard panels. Specialty assays like LC-MS/MS testosterone or equilibrium dialysis free testosterone may take 7 to 10 business days [13].

After labs return, consultation scheduling depends on provider availability. New patient slots at popular concierge clinics often book 1 to 2 weeks out. Once the consultation occurs and a prescription is written, compounding pharmacy turnaround and shipping adds another 3 to 7 business days.

Patients can accelerate the process by completing the health history promptly, scheduling labs the same week they receive the requisition, and selecting the earliest available consultation slot. Having prior lab results available (within 3 to 6 months) may also speed the initial assessment, though most providers will want their own baseline panel for liability and completeness reasons.